Cargando…
Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies
Vasoactive intestinal peptide (VIP) plays diverse and important role in human physiology and physiopathology and their receptors constitute potential targets for the treatment of several diseases such as neurodegenerative disorder, asthma, diabetes, and inflammatory diseases. This article reviews th...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483716/ https://www.ncbi.nlm.nih.gov/pubmed/23115557 http://dx.doi.org/10.3389/fendo.2012.00129 |
_version_ | 1782248049025744896 |
---|---|
author | Langer, Ingrid |
author_facet | Langer, Ingrid |
author_sort | Langer, Ingrid |
collection | PubMed |
description | Vasoactive intestinal peptide (VIP) plays diverse and important role in human physiology and physiopathology and their receptors constitute potential targets for the treatment of several diseases such as neurodegenerative disorder, asthma, diabetes, and inflammatory diseases. This article reviews the current knowledge regarding the two VIP receptors, VPAC(1) and VPAC(2), with respect to mechanisms involved in receptor activation, G protein coupling, signaling, regulation, and oligomerization. |
format | Online Article Text |
id | pubmed-3483716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-34837162012-10-31 Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies Langer, Ingrid Front Endocrinol (Lausanne) Endocrinology Vasoactive intestinal peptide (VIP) plays diverse and important role in human physiology and physiopathology and their receptors constitute potential targets for the treatment of several diseases such as neurodegenerative disorder, asthma, diabetes, and inflammatory diseases. This article reviews the current knowledge regarding the two VIP receptors, VPAC(1) and VPAC(2), with respect to mechanisms involved in receptor activation, G protein coupling, signaling, regulation, and oligomerization. Frontiers Media S.A. 2012-10-30 /pmc/articles/PMC3483716/ /pubmed/23115557 http://dx.doi.org/10.3389/fendo.2012.00129 Text en Copyright © Langer. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) , which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc. |
spellingShingle | Endocrinology Langer, Ingrid Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies |
title | Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies |
title_full | Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies |
title_fullStr | Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies |
title_full_unstemmed | Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies |
title_short | Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies |
title_sort | mechanisms involved in vpac receptors activation and regulation: lessons from pharmacological and mutagenesis studies |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483716/ https://www.ncbi.nlm.nih.gov/pubmed/23115557 http://dx.doi.org/10.3389/fendo.2012.00129 |
work_keys_str_mv | AT langeringrid mechanismsinvolvedinvpacreceptorsactivationandregulationlessonsfrompharmacologicalandmutagenesisstudies |